Form D · Pharmaceuticals
Sun BioPharma Research, Inc.
Waconia, MN · CIK 0001544125
Offering snapshot reported Sep 17, 2015 · SEC filing
- Reported sold
- $1.18M Offering amount: $1.18M
- Investors reported
- 20 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 4, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 17, 2015 | Initial | $1,175,000 | No comparison | 20 | SEC filing |
| Feb 4, 2014 | Initial | $3,100,000 | No comparison | 23 | SEC filing |
| Jun 28, 2013 | Amendment | $2,325,000 | $1,425,000vs May 23, 2013 | 10 | SEC filing |
| May 23, 2013 | Initial | $900,000 | No comparison | 3 | SEC filing |
| Mar 12, 2012 | Initial | $548,898 | No comparison | 10 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-247791
Source: Form D, filed Sep 17, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael T. Cullen | Director, Executive |
| Suzanne Gagnon | Director, Executive |
| Ryan R. Gilbertson | Executive |
| Jeffrey R. Harder | Director |
| Paul M. Herron | Director, Executive |
| Christopher R. Johnson | Executive |
| Randall L. Johnson | Executive |
| David B. Kaysen | Director, Executive |
| Clifford F. Mc Curdy, Iii | Director, Executive |
| Thomas X. Neenan | Director, Executive |
| Douglas M. Polinsky | Director, Executive |
| Daniel E. Ryweck | Executive |
| Paul W. Schaffer | Director |
| Donald R. Schemel | Director |
| D. Robert Schemel | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
712 Vista Blvd. #305
Waconia, MN, 55387
Waconia, MN, 55387